FDA Investigator Diane C Thibodeau

Diane C Thibodeau has conducted inspections on 158 sites in 1 countries as of 07 Jun 2012. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
158
Last Inspection Date:
07 Jun 2012
Investigator Role:
FDA Investigator
Redica ID:
100003683
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Diane C Thibodeau:
Adetutu M Gidado, Alexander V Gontcharov, Alice C Silva, Alice S Tsao, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Andrew M Barlow, Anthony C Warchut, Anthony N Onianwa, Anthony W Thomas, Asia D Clark, Betsy C Galliher, Blake C Hamann, Brandy N Lepage, Brenna L Macdowell, Byungja E Marciante, Camerson E Moore, Carla C Tuite, Christian F Gomez Lugo, Christine H Lee, Christine L Williams, Christine M Whitby, CSO, Christopher J Cruciotti, Christopher Janik, Chunsheng Cai, PhD, Clinton K George, Courtney N Long, Cynthia F Kleppinger, MD, Darin S Wiegers, Daryl A Dewoskin, David R Delucia, Deborah A Greco, Diane M Prince, Dien N Nguyen, Dominic R Frasca, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward J Janik, Elizabeth B Griffin, Emily J Schramm, Eric C Schmitt, Erich P Garger, Erin I Keith, Evan Tong, Gabrielle J Swain, Gale E Ryan, George T Allen, Jr, Gerard D Difiore, Hang N Guo, Helen B Ricalde, Janete F Guardia, Jeffery A Hangartner, Jeffrey J Thibodeau, John A Hollings, John J Thibodeau, John P Mistler, John P Shelton, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose A Torres, Joshua L Gibbs, Joyce A Kellett, Justine M Corson, Kenneth H Williams, Kent A Conforti, Kimberly M White, Kristina J Donohue, LCDR Debra Emerson, Linda L Green, Lirissia Mccoy, Lorayne A Mcguinness, Margaret M Sands, Mark R Mcclain, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Maura Rooney, Maya M Davis, Megan A Haggerty, Meisha A Mandal, Miah Jung, Michael G Mayfield, Michael P Anthony, Michelle M Noe Varga, Michelle Rfrazier Jessen, PhD, Mikayla K Deardorff, Nancy M Espinal, Nealie C Newberger, Nina Yang, Paige R Mccoy, Pamela N Agaba, Paul E Stein, Paul Lihong Yeh, PhD, Peter R Lenahan, Philip Kreiter, Rapti D Madurawe, Rebecca B Welch, Richard F Hapke, Richard H Penta, Richard L Licari, Robert J Martin, Robert O'brian, Rupa Pradhan, Samir C Gala, Sarah K Graham, Sean R Marcsisin, Sharon K Gershon, Sherri N Rohlf, MD, Simone E Pitts, Slater K Bartlett, Stephanie M Roberts Pedotti, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen R Souza, Steven C Nattrass, Susan M Jackson, Susanne M Richardson, MS RAC, Suzanne M Healy, Tanya R Syffrard, Todd D Alspach, Tomika L Crafter, Troy R Petrillo, Tyanna N Hadley, Victoria M Daddeo, Xiaojun Yan, Yvins Dezan

Diane C Thibodeau's Documents

Publish Date Document Type Title
August, 2009 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2009-08-11
July, 2011 FDA 483 Miyoshi America, Inc. - Form 483, 2011-07-20
April, 2009 FDA 483 Holland Company - Form 483, 2009-04-17
January, 2007 FDA 483 Alexion Pharmaceuticals, Inc. - Form 483, 2007-01-19
December, 2007 FDA 483 Ecometics, Inc. - Form 483, 2007-12-07
November, 2007 FDA 483 A&S Pharmeceutical Corporation - Form 483, 2007-11-13
April, 2006 FDA 483 Ecometics, Inc. - Form 483, 2006-04-10
May, 2008 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2008-05-15
June, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-06-06
December, 2009 FDA 483 Mannkind Corporation - Form 483, 2009-12-04
October, 2002 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2002-10-03
April, 2010 FDA 483 RHG & Company Inc. - Form 483, 2010-04-23
January, 2012 FDA 483 William McGee - Form 483, 2012-01-13
May, 2006 FDA 483 Unilever HPC - Form 483, 2006-05-08
June, 2006 FDA 483 Computerx Phamacy, Inc. - Form 483, 2006-06-09
February, 2006 FDA 483 Syntac Coated Products LLC - Form 483, 2006-02-13
April, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-04-30
October, 2009 FDA 483 Oraceutical LLC - Form 483, 2009-10-28
May, 2009 FDA 483 Phoenix Divina Products Llc - Form 483, 2009-05-01
June, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-05-07
January, 2010 FDA 483 Milbar Laboratories, Inc. - Form 483, 2010-01-27
July, 2010 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2010-07-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more